Tongxinluo Improve High on Clopidogrel Platelet Reactivity Patients With Coronary Heart Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
Tongxinluo is a kind of Chinese patent drug,which could promote blood circulation.Recent reports suggested that tongxinluo\'s effectiveness in reducing the thrombin activity.In this prospective randomized study,all patients in control group will receive blank placebo ,all patients in test group will receive tongxinluo.All patients will be followed up for one year.
Epistemonikos ID: 8a775a65d54bfe52693df189570e1f97506b4e0c
First added on: May 11, 2024